6-31779171-C-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_006295.3(VARS1):​c.3522G>C​(p.Gln1174His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000307 in 1,605,450 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 4 hom. )

Consequence

VARS1
NM_006295.3 missense

Scores

3
15

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: -0.394

Publications

1 publications found
Variant links:
Genes affected
VARS1 (HGNC:12651): (valyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. The protein encoded by this gene belongs to class-I aminoacyl-tRNA synthetase family and is located in the class III region of the major histocompatibility complex. [provided by RefSeq, Jul 2008]
VARS1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007817298).
BP6
Variant 6-31779171-C-G is Benign according to our data. Variant chr6-31779171-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 3040947.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0015 (228/152346) while in subpopulation AFR AF = 0.00522 (217/41582). AF 95% confidence interval is 0.00465. There are 0 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS1NM_006295.3 linkc.3522G>C p.Gln1174His missense_variant Exon 29 of 30 ENST00000375663.8 NP_006286.1 P26640-1A0A024RCN6
VARS1XM_005249362.3 linkc.3525G>C p.Gln1175His missense_variant Exon 29 of 30 XP_005249419.1
VARS1XM_047419296.1 linkc.3525G>C p.Gln1175His missense_variant Exon 28 of 29 XP_047275252.1
VARS1XM_047419297.1 linkc.3522G>C p.Gln1174His missense_variant Exon 28 of 29 XP_047275253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS1ENST00000375663.8 linkc.3522G>C p.Gln1174His missense_variant Exon 29 of 30 1 NM_006295.3 ENSP00000364815.3 P26640-1
VARS1ENST00000463184.1 linkn.*59G>C downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00150
AC:
228
AN:
152228
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00523
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000423
AC:
95
AN:
224664
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00630
Gnomad AMR exome
AF:
0.000249
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000203
Gnomad OTH exome
AF:
0.000182
GnomAD4 exome
AF:
0.000182
AC:
265
AN:
1453104
Hom.:
4
Cov.:
32
AF XY:
0.000151
AC XY:
109
AN XY:
722774
show subpopulations
African (AFR)
AF:
0.00630
AC:
209
AN:
33172
American (AMR)
AF:
0.000418
AC:
18
AN:
43012
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25794
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39556
South Asian (SAS)
AF:
0.0000351
AC:
3
AN:
85576
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51154
Middle Eastern (MID)
AF:
0.000523
AC:
3
AN:
5732
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1109130
Other (OTH)
AF:
0.000500
AC:
30
AN:
59978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00150
AC:
228
AN:
152346
Hom.:
0
Cov.:
33
AF XY:
0.00157
AC XY:
117
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00522
AC:
217
AN:
41582
American (AMR)
AF:
0.000588
AC:
9
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
12
23
35
46
58
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000515
Hom.:
0
Bravo
AF:
0.00171
ExAC
AF:
0.000462
AC:
54
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Jun 16, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

VARS1-related disorder Benign:1
Sep 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
9.9
DANN
Benign
0.97
DEOGEN2
Benign
0.0093
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.37
FATHMM_MKL
Uncertain
0.76
D
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
-0.39
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.074
Sift
Benign
0.12
T
Sift4G
Benign
0.12
T
Polyphen
0.88
P
Vest4
0.21
MutPred
0.37
Loss of glycosylation at P1171 (P = 0.1614);
MVP
0.22
MPC
0.64
ClinPred
0.012
T
GERP RS
0.45
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.018
gMVP
0.41
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200588763; hg19: chr6-31746948; API